NCT06952855View on ClinicalTrials.gov

Observationa Study is a Prospective and Multi-institutional Observational Study.

CompletedOBSERVATIONAL
Enrollment

5,536

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

April 23, 2025

Study Completion Date

April 23, 2025

Conditions
Erosive Reflux DiseaseHeartburnAcid Regurgitation
Trial Locations (1)

15865

Goodbreath Medical Center, Seoul

Sponsors
All Listed Sponsors
lead

Jeil Pharmaceutical Co., Ltd.

INDUSTRY